The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.
about
Optimising stroke prevention in non-valvular atrial fibrillationAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.Mechanoelectrical feedback regulates the arrhythmogenic activity of pulmonary veins.Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.Do we need pharmacological therapy for atrial fibrillation in the ablation era?Electrical cardioversion for AF-the state of the art.Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).The Role Of Renin Angiotensin System In Atrial Fibrillation.Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.Adjuvant therapy for atrial fibrillation.Upstream effect for atrial fibrillation: still a dilemma?Atrial fibrillation and inflammation.Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channelsNovel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion.Hypertension and ethnic group: eplerenone may have role in hypertension related atrial fibrillation.Survivors of ventricular fibrillation have persistent cardiovascular risk factors late in follow-up.Irbesartan-mediated AT1 receptor blockade attenuates hyposmotic-induced enhancement of I Ks current and prevents shortening of action potential duration in atrial myocytes.Can valsartan reduce the occurrence of atrial fibrillation in heart failure patients?The impact of suppressing the renin-angiotensin system on atrial fibrillation.Eplerenone might affect atrial fibrosis in patients with hypertension.Renin-angiotensin system blocker use may be associated with suppression of atrial fibrillation recurrence after pulmonary vein isolation.Relationship between -344T/C polymorphism in the aldosterone synthase gene and atrial fibrillation in patients with essential hypertension.Increased Plasma Aldosterone during Atrial Fibrillation Declines following Cardioversion
P2860
Q28200609-5ECBB5AD-1E58-4623-BD6A-3823D79B2058Q33798432-0A032518-5830-41FA-A4F8-6DFC00280FA2Q35773002-DC7E9683-1196-4D1D-8D2B-3D06B2BBEDC5Q36283707-C10656A3-15C6-4EBF-9BD3-B28ACAD04E5AQ36433583-E9A9BB47-2522-414F-B33E-A05D7EDEEFEEQ36752772-4C5B0822-1367-4942-AC4C-8DBA043480D7Q36793204-9153E123-F570-4F5D-BC68-C4D43CA34AA7Q37098363-3796CDCE-E087-4128-AB54-5FC87C673A4EQ37469038-D7280ADB-1956-4434-BD50-3473D32B91F8Q37506170-B818A275-7257-48B6-9292-347930A82F78Q37656338-27D499BD-042E-46C9-8BD5-2E248ACED50BQ37804417-A79BD03E-2F00-4FD9-89BC-8694D2318FB3Q37821236-3B9F27AE-EDEA-49D9-86E8-4AA1237BC6E9Q39300430-A7EF4CD2-D2A1-40B1-B774-BEE9912F73ADQ40404466-48F6D042-9F87-482D-B7B4-A446F413F496Q40544958-6DE88BA6-8E0E-4F95-BBD8-D8F6D21341E5Q42978065-AF60486C-6B5D-4B14-B7D8-BF507B1CC285Q44889774-F143A764-D7F9-4FAA-862E-3468979DCDC3Q45054461-8EFC9C64-7FD6-4D62-B07D-2D22805BA175Q46722766-3D70FA37-97B8-43FA-A4FE-31F7A06D8BBCQ46882740-3528F101-93D5-483A-92D1-E8B3D2EAF78DQ48169152-964592D8-36FC-4A99-9834-9C7016A23241Q50554432-953087A2-B2CB-4780-AC3D-5F2A6661D6F7Q54353741-1D64ED3F-7CC5-43A4-B558-CB59B26791CFQ57681709-1AD9363D-96A5-44A7-BC57-61F2EFFB614C
P2860
The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The role of angiotensin recept ...... ed controlled clinical trials.
@ast
The role of angiotensin recept ...... ed controlled clinical trials.
@en
type
label
The role of angiotensin recept ...... ed controlled clinical trials.
@ast
The role of angiotensin recept ...... ed controlled clinical trials.
@en
prefLabel
The role of angiotensin recept ...... ed controlled clinical trials.
@ast
The role of angiotensin recept ...... ed controlled clinical trials.
@en
P2093
P2860
P1476
The role of angiotensin recept ...... zed controlled clinical trials
@en
P2093
Antonio H Madrid
Carlos Escobar
Concepción Moro
Concepción Muños-Tinoco
Irene Marín
José M G Rebollo
P2860
P304
P356
10.1111/J.1540-8159.2004.00645.X
P577
2004-10-01T00:00:00Z